People

Jeffrey Goble Joins ThermoFab’s Advisory Board

New board member is a founder and current president/ CEO of Arterex.

By: Michael Barbella

Managing Editor

ThermoFab has appointed Jeffrey Goble to its Board of Advisors, effective immediately.

“We are delighted to welcome Jeff to the Advisory Board,” Culper Capital Partners Non-Executive Chairman and Chief Investment Officer Adam Cook said. “Jeff brings an exceptional track record of building and scaling global medtech manufacturing platforms. His industry knowledge, visionary leadership, and history of founding and growing successful companies in the medical device space make him a tremendous asset to ThermoFab’s continued growth. Our CEO Mark Rauenzahn, Board Member Declan Smyth (medical device executive) and Board Member Dean Schauer (CEO and president of Confluent Medical Technologies), all are leaders with deep roots in the medical device space. I’m personally excited to see this team drive the next phase of our journey.”

Goble is a founder and current president/CEO of Arterex, a diversified global contract development and manufacturing organization serving medtech OEMs and innovators. With 13 facilities across five countries and four continents, Arterex is a major player in the medical technology manufacturing space. Prior to Arterex, Goble was a founder and served as president/CEO of Providien LLC, a diversified manufacturer of medical devices and outsourced manufacturing services for the life sciences industry, which was acquired by Carlisle Companies in 2019. He also held executive leadership positions at Medegen Inc., where he led the company through a 2010 acquisition to CareFusion.

“I’m honored to join ThermoFab’s Advisory Board,” Goble stated. “ThermoFab is well-positioned for continued growth. I’m excited to contribute to the next phase of ThermoFab’s future alongside Adam, Declan, and the rest of the leadership team.”

ThermoFab is a provider of engineered heavy gauge plastic enclosures and related single use components for the medical device, life sciences, and other critical highly regulated industries. Applications include surgical robotics, organ transport devices, genetic sequencing devices, people scanning technologies, autonomous robots, and information technology, among others. With a wealth of experience in managing large, multi-part projects, ThermoFab’s capabilities encompass the entire production lifecycle, from design and initial prototyping to full-scale production and assembly—with a team working with clients to bring concepts to life.

Culper Capital Partners is a private investment firm that invests both debt and equity in middle market companies that seek true partnership solutions. Culper seeks to revolutionize the meaning of private equity by working with its portfolio companies to drive value for their customers, employees, the community, and shareholders alike.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters

Topics